Related Experiment Video
Updated: Oct 7, 2025

A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons
Published on: November 7, 2014
Ketamine: A Potential Adjunct for Severe Benzodiazepine Withdrawal
Kristen Purcell1, Pollianne W Bianchi2, Daniel Glenn3
1Emergency Medicine, Midwestern University Chicago College of Osteopathic Medicine, Downers Grove, USA.
Ketamine may effectively treat severe benzodiazepine withdrawal symptoms when standard treatments fail. This case report highlights ketamine as a potential adjunct therapy for benzodiazepine (BZDs) withdrawal management.
Area of Science:
- Neuroscience
- Pharmacology
- Emergency Medicine
Background:
- Benzodiazepine (BZD) withdrawal can be life-threatening, necessitating effective medical management.
- Current BZD withdrawal treatments include benzodiazepines, anxiolytics, and anticonvulsants.
- Ketamine is an emerging treatment for alcohol withdrawal, suggesting potential for other substance withdrawal syndromes.
Observation:
- A 27-year-old male presented with severe drug withdrawal symptoms, including benzodiazepine and opioid abuse history.
- The patient exhibited persistent severe withdrawal despite aggressive standard medical interventions.
- An infusion of ketamine (0.5 mg/kg over 30 minutes) was administered.
Findings:
- Ketamine administration resulted in significant improvement of the patient's withdrawal symptoms.
- This suggests ketamine may be effective in managing acute, severe benzodiazepine withdrawal.
- The patient's response indicates a potential role for ketamine beyond its current uses.
Implications:
- Ketamine shows promise as an adjunctive treatment for refractory benzodiazepine withdrawal.
- Further research is warranted to explore ketamine's efficacy and safety in BZD withdrawal.
- This case may inform clinical practice and future therapeutic strategies for substance withdrawal.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Barbiturates
Anxiolytic Drugs: Benzodiazepines and Buspirone